PHILIP W HUNT

Allopathic & Osteopathic Physicians|Family Medicine LAFAYETTE, TN NPI 1508916586

General Payments — all program years on this page

$1,629.61

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 80
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $332.39 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $332.3915

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $292.7114
2019 $241.8112
2020 $75.405
2021 $168.669
2022 $214.4310
2023 $304.2115
2024 $332.3915

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097645082 Novo Nordisk Inc $27.88 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103955498 ABBVIE INC. $28.41 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103955500 ABBVIE INC. $27.04 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103955502 ABBVIE INC. $28.71 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103955504 ABBVIE INC. $21.88 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104198385 AstraZeneca Pharmaceuticals LP $21.32 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105815241 AstraZeneca Pharmaceuticals LP $17.63 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105890790 AstraZeneca Pharmaceuticals LP $17.63 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118911137 Otsuka America Pharmaceutical, Inc. $22.33 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118911139 Otsuka America Pharmaceutical, Inc. $16.46 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118911141 Otsuka America Pharmaceutical, Inc. $24.24 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144609027 Xeris Pharmaceuticals, Inc. $16.32 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153467863 Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.31 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153519060 Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.78 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153656859 Salix Pharmaceuticals, a division of Bausch Health US, LLC $20.45 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.